We are live on ! Find out more
FP

Foundry Partners Portfolio holdings

AUM $1.89B
1-Year Est. Return 9.84%
This Fund
S&P 500
This Quarter Est. Return
+9.74%
1 Year Est. Return
+9.84%
3 Year Est. Return
+44.42%
5 Year Est. Return
+233.04%
10 Year Est. Return
+297.72%
AUM
$2.66B
AUM Growth
+$232M
Cap. Flow
+$22.2M
Cap. Flow %
0.84%
Top 10 Hldgs %
12.87%
Holding
426
New
39
Increased
168
Reduced
164
Closed
32

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$37.1M
2
KMB icon
Kimberly-Clark
KMB
+$18.5M
3
HPQ icon
HP
HPQ
+$14.6M
4
BMY icon
Bristol-Myers Squibb
BMY
+$14.5M
5
PARA
Paramount Global Class B
PARA
+$13.9M

Top Sells

Rank Stock Value
1
PM icon
Philip Morris
PM
+$22.8M
2
JNJ icon
Johnson & Johnson
JNJ
+$20.4M
3
CMCSA icon
Comcast
CMCSA
+$17.1M
4
CSCO icon
Cisco
CSCO
+$9.98M
5
AYR
Aircastle Ltd
AYR
+$9.4M

Sector Composition

Rank Sector Weight
1 Financials 25.23%
2 Industrials 14.39%
3 Technology 10.75%
4 Healthcare 8.72%
5 Consumer Discretionary 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLNX
301
DELISTED
Mellanox Technologies, Ltd.
MLNX
$1.33M 0.05%
11,348
-269
-2% -$30.6K
NBN icon
302
Northeast Bank
NBN
$1.09B
$1.32M 0.05%
59,840
-5,490
-8% -$121K
ETSY icon
303
Etsy
ETSY
$7.68B
$1.29M 0.05%
29,166
-691
-2% -$32.9K
ANIK icon
304
Anika Therapeutics
ANIK
$195M
$1.29M 0.05%
24,890
-14,725
-37% -$855K
OOMA icon
305
Ooma
OOMA
$532M
$1.28M 0.05%
96,624
-2,305
-2% -$28.1K
BPMC
306
DELISTED
Blueprint Medicines
BPMC
$1.26M 0.05%
15,766
-1,226
-7% -$91.8K
DHX icon
307
DHI Group
DHX
$163M
$1.24M 0.05%
412,918
+85,518
+26% +$291K
INGN icon
308
Inogen
INGN
$171M
$1.22M 0.05%
17,892
+2,893
+19% +$181K
FNKO icon
309
Funko
FNKO
$319M
$1.21M 0.05%
70,329
-17,174
-20% -$280K
METC icon
310
Ramaco Resources Class A
METC
$731M
$1.2M 0.05%
346,806
-152,441
-31% -$510K
ARTNA icon
311
Artesian Resources
ARTNA
$350M
$1.18M 0.04%
31,625
-2,850
-8% -$105K
FISV
312
Fiserv Inc
FISV
$26.6B
$1.16M 0.04%
10,022
ZTS icon
313
Zoetis
ZTS
$31.3B
$1.14M 0.04%
8,611
-125
-1% -$15.5K
AAPL icon
314
Apple
AAPL
$4.72T
$1.11M 0.04%
15,080
-2,828
-16% -$182K
MSFT icon
315
Microsoft
MSFT
$2.83T
$1.1M 0.04%
6,955
V icon
316
Visa
V
$669B
$1.08M 0.04%
5,772
APH icon
317
Amphenol
APH
$194B
$1.08M 0.04%
39,864
CALM icon
318
Cal-Maine
CALM
$4.18B
$1.07M 0.04%
25,111
-596
-2% -$24.8K
CMD
319
DELISTED
Cantel Medical Corporation
CMD
$1.03M 0.04%
14,590
-7,016
-32% -$509K
ICE icon
320
Intercontinental Exchange
ICE
$81B
$993K 0.04%
10,728
YELP icon
321
Yelp
YELP
$1.35B
$988K 0.04%
28,367
-670
-2% -$22.7K
EW icon
322
Edwards Lifesciences
EW
$48.3B
$982K 0.04%
12,624
-558
-4% -$43.6K
GWB
323
DELISTED
Great Western Bancorp, Inc.
GWB
$971K 0.04%
27,957
-686
-2% -$23.7K
ICD
324
DELISTED
Independence Contract Drilling, Inc.
ICD
$964K 0.04%
48,360
-10,310
-18% -$184K
LGND icon
325
Ligand Pharmaceuticals
LGND
$6.06B
$937K 0.04%
14,409
-343
-2% -$22.9K

Similar funds

Foundry Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Foundry Partners held 426 positions worth $2.66B, up 9.6% from $2.42B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Foundry Partners's Q4 2019 filing shows 39 new, 168 increased, 164 reduced and 32 closed positions. Its largest new stake was Kimberly-Clark: 136,887 shares worth $18.8M. The largest sale was Philip Morris, an estimated $22.8M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 24% a quarter earlier, followed by Industrials and Technology.

  • Foundry Partners's largest Q4 2019 buy was Kimberly-Clark: 136,887 shares worth $18.8M.
  • Foundry Partners added most to Intel in Q4 2019, an estimated $37.1M increase.
  • Foundry Partners's biggest Q4 2019 reduction was Aircastle Ltd, cutting an estimated $9.4M.
  • Foundry Partners fully exited Philip Morris in Q4 2019, selling an estimated $22.8M.
  • Foundry Partners's ten largest holdings make up 13% of its $2.66B portfolio in Q4 2019.
  • Foundry Partners opened 39 new positions and closed 32 in Q4 2019.
  • Foundry Partners's portfolio value rose 9.6% quarter-over-quarter to $2.66B.

Based on Foundry Partners's 13F filing for Q4 2019, filed 10 Feb 2020.